RVXCF (Resverlogix) Sale Of Property, Plant, Equipment : $0.00 Mil (TTM As of Sep. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Resverlogix Sale Of Property, Plant, Equipment?

Resverlogix's sale of property, plant, equipment for the three months ended in Sep. 2024 was $0.00 Mil. It means Resverlogix gained $0.00 Mil from selling property, plant, and equipment. Resverlogix's sale of property, plant, equipment for the trailing twelve months (TTM) ended in Sep. 2024 was $0.00 Mil.

Compared with last quarter ($0.00 Mil in Jun. 2024 ), Resverlogix gained the same money from selling property, plant, and equipment in Sep. 2024 ($0.00 Mil).

Resverlogix Sale Of Property, Plant, Equipment Historical Data

The historical data trend for Resverlogix's Sale Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Resverlogix Sale Of Property, Plant, Equipment Chart

Resverlogix Annual Data

Trend

Apr14

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Dec21

Dec22

Dec23

Sale Of Property, Plant, Equipment

Get a 7-Day Free Trial

Resverlogix Quarterly Data
	Oct19	Jan20	Apr20	Jul20	Oct20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Sale Of Property, Plant, Equipment	Get a 7-Day Free Trial															-	-	-	-	-

Resverlogix Sale Of Property, Plant, Equipment Calculation

The amount earned to sell PPE.

Sale Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Resverlogix Sale Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of Resverlogix's Sale Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.

Resverlogix Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Resverlogix Corp (OTCPK:RVXCF) » Definitions » Sale Of Property, Plant, Equipment

Comparable Companies

Traded in Other Exchanges

0VF9:UK RVX:Canada

Address

4820 Richard Road South West, Suite 300, Calgary, AB, CAN, T3E 6L1

Website

https://www.resverlogix.com

Resverlogix Corp clinical-stage biotechnology company. The company is developing apabetalone (RVX-208), a first-in-class, small molecule that is a selective BET (bromodomain and extra terminal) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. Apabetalone is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. This selective inhibition of apabetalone on BD2 produces a specific set of biological effects with potentially important benefits for patients with chronic disease including cardiovascular disease (CVD) and associated comorbidities, and COVID-19.